You are here

  • Home
  • Online First
  • Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study

Article info

Article menu
Download PDFPDF
Original research
Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study

Authors

  • Huimei Zhou Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Qian Liu Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Depu Zhang Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China PubMed articlesGoogle scholar articles
  • Qingshui Li Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China PubMed articlesGoogle scholar articles
  • Dongyan Cao Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Ninghai Cheng Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Xirun Wan Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Ying Zhang Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Fengzhi Feng Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Yang Xiang Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Jiaxin Yang Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jiaxin Yang, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China; jiaxin_yang{at}sina.com
View Full Text

Citation

Zhou H, Liu Q, Zhang D, et al
Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study
International Journal of Gynecologic Cancer Published Online First: 29 July 2024. doi: 10.1136/ijgc-2024-005386

Publication history

  • Received February 20, 2024
  • Accepted June 25, 2024
  • First published July 29, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.